Northwest Biotherapeutics Company

Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.

Last Funding Type: Post-IPO Debt
Funding Status: IPO
Headquarters: Bethesda, Maryland, United States
Founded Date: 1998-01-01
Last Funding Date: 2021-11-22
Total Funding: 169400000
Employee Number: 11-50
Estimated Revenue: Less than $1M
Investors Number: 1
Industry: Dendritic Cells